Shining on Major News: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), Memorial Resource Development Corp. (NASDAQ:MRD), Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD),

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced financial results for the fourth quarter and full year ended December 31, 2015. Adamas reported a net loss attributable to common stockholders of $51.8 million, or $2.86 per share, for the year ended December 31, 2015. In the prior year, the company reported net income attributable to common stockholders of $9.1 million, or $0.53 per diluted share, as a result of $55.0 million of development milestones from Forest Laboratories Holdings Limited (“Forest”) recorded as revenue during the year ended December 31, 2014.

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) belongs to Healthcare sector. Its net profit margin is -99.40% and weekly performance is -16.99%. On last trading day company shares ended up at $12.80.

Memorial Resource Development Corp. (NASDAQ:MRD) reported Net interest expense during the fourth quarter 2015 was $10.9 million, including amortization of deferred financing fees of approximately $0.8 million. This compares to net interest expense during the fourth quarter 2014 of $5.9 million, including amortization of deferred financing fees of approximately $0.7 million. MRD reported Adjusted Net Income for the fourth quarter 2015 of $9.2 million compared to $4.8 million for the fourth quarter 2014.

Memorial Resource Development Corp. (NASDAQ:MRD) shares decreased -17.32% in last trading session and ended the day at $8.45. MRD Gross Margin is 69.60% and its return on assets is 6.40%. Memorial Resource Development Corp. (NASDAQ:MRD) quarterly performance is -48.00%.

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced that its Chief Medical Officer, Dr. Maya Halpern, has notified the Company that she will retiring from Galmed as Chief Medical Officer and from its Board of Directors effective as of April 9, 2016 due to her reaching retirement age.

On 24 February, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares decreased -8.37% and was closed at $4.45. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) year to date (YTD) performance is -41.48%.

On 16 February, Tile Shop Holdings, Inc. (NASDAQ:TTS) reported Net sales grew 13.5% to $71.9 million for the fourth quarter ended December 31, 2015 compared with $63.3 million for the fourth quarter ended December 31, 2014. The $8.6 million increase in net sales was due to a comparable store sales increase of 9.8%, or $6.2 million in the quarter and incremental net sales of $2.4 million from stores not included in the comparable store base.

Tile Shop Holdings, Inc. (NASDAQ:TTS) ended the last trading day at $12.92. Company weekly volatility is calculated as 3.47% and price to cash ratio as 64.52. Tile Shop Holdings, Inc. (NASDAQ:TTS) showed a weekly performance of -1.97%.

Koss Corporation (NASDAQ:KOSS), the U.S. based high-fidelity headphone company, announced that it has settled the claims between Koss and American Express Company, et al., in the lawsuit pending in the Superior Court of Maricopa County, Arizona, Case No. CV 2010-006631.

Koss Corporation (NASDAQ:KOSS) shares advanced 0.47% in last trading session and ended the day at $2.15. KOSS Gross Margin is 34.70% and its return on assets is 3.60%. Koss Corporation (NASDAQ:KOSS) quarterly performance is 2.38%.

Leave a Reply

Your email address will not be published. Required fields are marked *